Scientific data related to HIV / AIDS

 

support for the test-and-treat approach

Growing scientific evidence shows that the test-and-treat approach can control HIV/AIDS in a cost-effective manner. In response, some programs are beginning to shift treatment protocols to begin antiretroviral drugs immediately after positive HIV tests.

Questions and answers: The START HIV treatment study – July 20, 2015

90-90-90: An ambitious treatment target to help end the AIDS epidemic – October 2014

Extra-couple HIV transmission in sub-Saharan Africa: A mathematical modelling study of survey dataFebruary 5, 2013

HIV treatment as prevention: Debate and commentary — Will early infection compromise treatment-as-prevention strategies?July 10, 2012

Current articles on treatment as prevention July 10, 2012

Expanding ART for treatment and prevention of HIV in South Africa: Estimated cost and cost-effectiveness 2011-2050February 13, 2012

Achieving universal access for human immunodeficiency virus and tuberculosis: Potential prevention impact of an integrated multi-disease prevention campaign in KenyaJanuary 28, 2012

CDC economic models show HIV treatment scale-up is cost-effective, can save money over timeJanuary 27, 2012

Affordability, cost and cost-effectiveness of universal anti-retroviral therapy for HIV – 2012

Role of fiscal policy in tackling the HIV/AIDS epidemic in Southern Africa – 2012

Economic returns to investment in AIDS treatment in low and middle income countries – October 5, 2011

ART in prevention of HIV and TB: Update on current research efforts – September 2011

Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting – September 2011

Harnessing the prevention benefits of antiretroviral treatment to address HIV and tuberculosis – September 2011

Modelling the impact of antiretroviral therapy on the epidemic of HIV – September 2011

Prevention of HIV-1 infection with early antiretroviral therapyJuly 18, 2011

Initiation of antiretroviral treatment protects uninfected sexual partners from HIV infection (HPTN Study 052) – May 12, 2011

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society – USA Panel – July 21, 2010

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study – July 18, 2010

Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco – June 10, 2010

Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA guidelines in British Columbia, Canada – June 7, 2010

Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis – May 27, 2010

Expanding access to HAART: A cost-effective approach for treating and preventing HIV – April 14, 2010

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study – April 30, 2009

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model – January 3, 2009

Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic – July 1, 2008

The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic – August 5, 2006

Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan – July 22, 2004